Literature DB >> 5577378

[Kinetics of tetracyclines in human. II. Excretion, penetration into normal and inflammed tissues, behavior in a case of renal insufficiency and in hemodialysis].

J Fabre, E Milek, P Kalfopoulos, G Mérier.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5577378

Source DB:  PubMed          Journal:  Schweiz Med Wochenschr        ISSN: 0036-7672


× No keyword cloud information.
  8 in total

1.  Acute pelvic inflammatory disease and clinical response to parenteral doxycycline.

Authors:  A W Chow; K L Malkasian; J R Marshall; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

2.  Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs.

Authors:  M Barza; R B Brown; C Shanks; C Gamble; L Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1975-12       Impact factor: 5.191

Review 3.  Pharmacokinetic considerations in the eradication of Helicobacter pylori.

Authors:  U Klotz
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

4.  A symposium on the tetracyclines: a major appraisal. Introduction.

Authors:  H C Neu
Journal:  Bull N Y Acad Med       Date:  1978-02

5.  Anaerobic lung infections treated with doxycycline.

Authors:  H Thadepalli; D Webb; J T Huang
Journal:  Bull N Y Acad Med       Date:  1978-02

6.  Antibiotic administration routes significantly influence the levels of antibiotic resistance in gut microbiota.

Authors:  Lu Zhang; Ying Huang; Yang Zhou; Timothy Buckley; Hua H Wang
Journal:  Antimicrob Agents Chemother       Date:  2013-05-20       Impact factor: 5.191

7.  An experimental model for pharmacokinetic analysis in renal failure.

Authors:  N E Duffee; R F Bevill; G D Koritz; D J Schaeffer
Journal:  J Pharmacokinet Biopharm       Date:  1990-02

8.  Serum level, half-life and apparent volume of distribution of doxycycline in geriatric patients.

Authors:  R Böcker; W Mühlberg; D Platt; C J Estler
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.